Shanrong Biotechnology Corp.
SRBT
$0.3216
-$0.3284-50.52%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | -4.07M | 184.30K | -447.40K | -744.70K | -1.03M |
| Total Depreciation and Amortization | 8.90K | 8.90K | 8.90K | 8.90K | 8.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 2.50K |
| Total Other Non-Cash Items | 3.36M | 0.00 | 0.00 | 21.50K | 41.30K |
| Change in Net Operating Assets | 363.80K | -329.20K | 235.70K | 602.10K | 590.30K |
| Cash from Operations | -336.40K | -136.00K | -202.80K | -112.20K | -385.70K |
| Capital Expenditure | -- | -- | -- | -- | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.20K | -4.20K | -- | -- | 7.90K |
| Cash from Investing | 4.20K | -4.20K | -- | -- | 6.90K |
| Total Debt Issued | -9.50K | 148.50K | 67.50K | 22.90K | 380.80K |
| Total Debt Repaid | -21.20K | -11.80K | -36.40K | -38.20K | -334.30K |
| Issuance of Common Stock | 385.00K | 0.00 | 0.00 | 250.00K | 310.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -- | -- | 0.00 |
| Cash from Financing | 354.30K | 136.70K | 31.00K | 234.70K | 356.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | 22.10K | -3.50K | -171.80K | 122.50K | -22.20K |
